# EDGAR Filing Document

**Accession Number:** 0001932231
**File Stem:** 0000000000-23-001066
**Filing Date:** 2023-2
**Character Count:** 7599
**Document Hash:** 0bb2d7dbf92f4b3f84a0fdc4ca0a1967
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000000000-23-001066.hdr.sgml**: 20230315

**ACCESSION NUMBER**: 0000000000-23-001066

**CONFORMED SUBMISSION TYPE**: UPLOAD

**PUBLIC DOCUMENT COUNT**: 2

**FILED AS OF DATE**: 20230201

**FILED FOR**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** NAVA HEALTH MD, LLC
- **CENTRAL INDEX KEY:** 0001932231
- **STANDARD INDUSTRIAL CLASSIFICATION:** SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE [8011]
- **IRS NUMBER:** 320416441
- **STATE OF INCORPORATION:** MD
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** UPLOAD

**BUSINESS ADDRESS:**
- **STREET 1:** 9755 PATUXENT WOODS DRIVE
- **STREET 2:** SUITE 100
- **CITY:** COLUMBIA
- **STATE:** MD
- **ZIP:** 21046
- **BUSINESS PHONE:** 4109102770

**MAIL ADDRESS:**
- **STREET 1:** 9755 PATUXENT WOODS DRIVE
- **STREET 2:** SUITE 100
- **CITY:** COLUMBIA
- **STATE:** MD
- **ZIP:** 21046

## Text-Extract

```

United States securities and exchange commission logo

                              February 1, 2023

       Bernaldo Dancel
       Chief Executive Officer
       NAVA HEALTH MD, LLC
       9755 Patuxent Woods Drive, Suite 100
       Columbia, Maryland 21046

                                                        Re: NAVA HEALTH MD, LLC
                                                            Amendment No. 2 to
Registration Statement on Form S-1
                                                            Filed January 30,
2023
                                                            File No. 333-268022

       Dear Bernaldo Dancel:

             We have reviewed your amended registration statement and have the
following
       comments. In some of our comments, we may ask you to provide us with
information so we
       may better understand your disclosure.

              Please respond to this letter by amending your registration
statement and providing the
       requested information. If you do not believe our comments apply to your
facts and
       circumstances or do not believe an amendment is appropriate, please tell
us why in your
       response.

              After reviewing any amendment to your registration statement and
the information you
       provide in response to these comments, we may have additional comments.

       Amendment No. 2 to Registration Statement on Form S-1, Filed January 30,
2023

       Risk Factors, page 11

   1.                                                   We note recent
instances of extreme stock price run-ups followed by rapid price declines
                                                        and stock price
volatility seemingly unrelated to company performance following a
                                                        number of recent
initial public offerings, particularly among companies with relatively
                                                        smaller public floats.
Revise to include a separate risk factor addressing the potential for
                                                        rapid and substantial
price volatility and any known factors particular to your offering that
                                                        may add to this risk
and discuss the risks to investors when investing in stock where the
                                                        price is changing
rapidly. Clearly state that such volatility, including any stock-run up,
                                                        may be unrelated to
your actual or expected operating performance and financial
                                                        condition or prospects,
making it difficult for prospective investors to assess the rapidly
                                                        changing value of your
stock.
 Bernaldo Dancel
NAVA HEALTH MD, LLC
February 1, 2023
Page 2
Use of Proceeds, page 42

2.    We note in your free writing prospectus filed January 30, 2023, you state
that one of your
      uses of proceeds for this offering is strategic acquisitions. Please
revise the Registration
      Statement to reflect this or advise.
       You may contact Tracie Mariner at 202-551-3744 or Al Pavot at
202-551-3738 if you
have questions regarding comments on the financial statements and related
matters. Please
contact Margaret Schwartz at 202-551-7153 or Laura Crotty at 202-551-7614 with
any other
questions.

                                                            Sincerely,

FirstName LastNameBernaldo Dancel                           Division of
Corporation Finance
                                                            Office of
Industrial Applications and
Comapany NameNAVA HEALTH MD, LLC
                                                            Services
February 1, 2023 Page 2
cc:       Rachel M. Jones, Esq.
FirstName LastName

```

### Attached PDF Documents

**Attachment 1:** `filename1`

![img-0.jpeg](img-0.jpeg)

CORPORATION FINANCE

# UNITED STATES  
SECURITIES AND EXCHANGE COMMISSION  
WASHINGTON, D.C. 20549

February 1, 2023

Bernaldo Dancel  
Chief Executive Officer  
NAVA HEALTH MD, LLC  
9755 Patuxent Woods Drive, Suite 100  
Columbia, Maryland 21046

# **Re: NAVA HEALTH MD, LLC**  
**Amendment No. 2 to Registration Statement on Form S-1**  
**Filed January 30, 2023**  
**File No. 333-268022**

Dear Bernaldo Dancel:

We have reviewed your amended registration statement and have the following comments. In some of our comments, we may ask you to provide us with information so we may better understand your disclosure.

Please respond to this letter by amending your registration statement and providing the requested information. If you do not believe our comments apply to your facts and circumstances or do not believe an amendment is appropriate, please tell us why in your response.

After reviewing any amendment to your registration statement and the information you provide in response to these comments, we may have additional comments.

Amendment No. 2 to Registration Statement on Form S-1, Filed January 30, 2023

Risk Factors, page 11

1. We note recent instances of extreme stock price run-ups followed by rapid price declines and stock price volatility seemingly unrelated to company performance following a number of recent initial public offerings, particularly among companies with relatively smaller public floats. Revise to include a separate risk factor addressing the potential for rapid and substantial price volatility and any known factors particular to your offering that may add to this risk and discuss the risks to investors when investing in stock where the price is changing rapidly. Clearly state that such volatility, including any stock-run up, may be unrelated to your actual or expected operating performance and financial condition or prospects, making it difficult for prospective investors to assess the rapidly changing value of your stock.

Bernaldo Dancel
NAVA HEALTH MD, LLC
February 1, 2023
Page 2

Use of Proceeds, page 42

2. We note in your free writing prospectus filed January 30, 2023, you state that one of your uses of proceeds for this offering is strategic acquisitions. Please revise the Registration Statement to reflect this or advise.

You may contact Tracie Mariner at 202-551-3744 or Al Pavot at 202-551-3738 if you have questions regarding comments on the financial statements and related matters. Please contact Margaret Schwartz at 202-551-7153 or Laura Crotty at 202-551-7614 with any other questions.

Sincerely,

Division of Corporation Finance
Office of Industrial Applications and
Services

cc: Rachel M. Jones, Esq.